Functional studies using prostate cancer cell lines suggest that the expression of the Galectin-3 is not regulated by AR, but other hormones and their receptors, such as ER, could be involved in the regulation of the expression of the Galectin-3. Here, LGALS3 is linked to prostate carcinoma.